Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Weight gain may contribute to increased fracture risk in women treated with rosiglitazone.

Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Abstract Text:

    j a pascoJ A Pasco,m j henryM J Henry,g c nicholsonG C Nicholson,j a pascoJ A Pasco,m j henryM J Henry,g c nicholsonG C Nicholson,

    Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Publishing Authors By Initials

    ja pascoJA Pasco,mj henryMJ Henry,gc nicholsonGC Nicholson,ja pascoJA Pasco,mj henryMJ Henry,gc nicholsonGC Nicholson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Journal Published:

    PUBLICATION TYPE: Letter

    Journal: Diabetic medicine : a journal of the British Diabe

    VOLUME: 24

    Page Numbers: 1173-4

    Journal Abbreviation: Diabet. Med.

    ISSN: 0742-3071

    DAY: 24

    MONTH: Oct

    YEAR: 2007

    Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8500858

    Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Weight gain may contribute to increased fracture risk in women treated with rosiglitazone. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Weight gain may contribute to increased fracture risk in women treated with rosiglitazone.

    AFFILIATION:

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Diabet Med

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Weight gain may contribute to increased fracture risk in women treated with rosiglitazone Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News